Prior to the pandemic, the average MMR vaccination rate at the county level stood at an already modest 93.92%. Post-pandemic data reflects a notable dip, with an average rate falling to 91.26%, marking a mean reduction of 2.67%. While seemingly small, this decline is epidemiologically significant, pushing many communities further away from the established 95% vaccination threshold required to sustain herd immunity against measles. The implications of slipping below this critical threshold risk a resurgence of outbreaks and loss of containment of viral transmission.

Of the 2,066 counties analyzed, a staggering 1,614—approximately 78%—reported decreases in the county-level vaccination rates. This widespread trend underscores the pandemic’s disruptive effect on routine childhood immunization programs. The altered healthcare access, resource reallocation to COVID-19 response, vaccine hesitancy exacerbated by misinformation, and interruptions to school-based vaccination campaigns likely contributed to this decline. Only a handful of states, including California, Connecticut, Maine, and New York, demonstrated a reversal with increases in median county vaccination rates, highlighting the considerable heterogeneity of vaccination dynamics across the nation.

This dataset, published in the highly regarded journal JAMA, coincides with an alarming rise in measles cases reported within the United States this year. Over one thousand instances have been confirmed, representing one of the highest annual case counts in more than thirty years, second only to the historically severe spike documented in 2019. Notably, the vast majority of these cases involve unvaccinated children, emphasizing the direct consequences of declining immunization coverage and underscoring the urgent need for targeted public health interventions.

Lauren Gardner, the senior author and director of Johns Hopkins University’s Center for Systems Science and Engineering, remarked on the critical importance of this dataset. Gardner, renowned for leading the data collection effort behind the globally utilized Johns Hopkins COVID-19 dashboard, highlighted the utility of high-resolution vaccination data to dissect complex epidemiological patterns. This granular information provides an essential tool for health authorities to predict measles transmission risk and to tailor vaccination strategies locally rather than relying on coarse state or national averages, which can mask underlying vulnerabilities.

The dataset expands upon existing state and national level statistics available from the Centers for Disease Control and Prevention (CDC), furnishing a more detailed landscape of MMR vaccination coverage variation. The evaluation reveals that vaccination patterns vary not only between states but also significantly within states, reflecting diverse socio-economic, cultural, and political factors influencing healthcare behaviors and access. Understanding these fine-scale disparities is crucial for designing precision public health approaches capable of arresting potential outbreaks before they escalate.

Researchers compiled two-dose MMR vaccination rates among kindergarteners by extracting data from individual state health department websites spanning from 2017 through 2024 where available. This extensive timeframe captures trends before, during, and after the COVID-19 pandemic. Overall, the dataset includes vaccination information from 2,237 counties across 38 states, rendering it one of the most comprehensive county-level vaccine coverage databases currently available in the United States.

This thorough documentation enables researchers and policymakers to monitor vaccination trends over time and spatially throughout the country. Equally, the data highlights the urgency to reverse declining vaccine uptake and to reinforce education and outreach programs to combat misinformation and vaccine hesitancy, which have intensified during the pandemic era. Strengthening public trust in vaccination programs is imperative to restore population immunity and to prevent future outbreaks of measles, mumps, and rubella, diseases that, although vaccine-preventable, can cause severe morbidity and mortality.

Continuous surveillance provided by this dataset empowers stakeholders to identify vulnerable counties exhibiting significant vaccination declines, enabling timely public health responses. Furthermore, such high-resolution data can inform mathematical models predicting the risk and spread of measles outbreaks, facilitating resource allocation targeted to high-risk communities. The data-driven approach advocated by Gardner’s team epitomizes a shift towards leveraging big data and advanced analytics in infectious disease control and prevention.

While the pandemic itself disrupted routine healthcare delivery and preventive measures, this dataset illustrates that the reprocussions extend beyond COVID-19, amplifying susceptibility to other infectious diseases with established prevention methods. The resurgence of measles cases paired with declining vaccination rates is a stark reminder that maintaining robust immunization systems is essential for safeguarding public health resilience, especially in the face of emerging global health challenges.

As measles remains one of the most transmissible human viruses, even slight reductions in vaccine coverage can precipitate outbreaks. The findings underscore the delicate balance of herd immunity and the consequences of perturbations within vaccination programs. The Johns Hopkins team’s research not only maps this landscape but also provides a transparent resource with open data available for download, encouraging collaborative efforts across academia, public health agencies, and policymakers to confront this emerging threat effectively.

The dataset authors include former adjunct assistant research scientist Ensheng Dong, graduate student Samee Saiyed, former research assistant Andreas Nearchou, undergraduate student Yamato Okura, and senior author Lauren Gardner, all affiliated with Johns Hopkins University. Their collective expertise in epidemiology, data science, and disease modeling fortifies the rigorous approach underpinning this pivotal contribution to infectious disease surveillance.

As public health communities digest these findings, there is a renewed call to action to bolster vaccination campaigns, enhance surveillance systems, and deploy innovative communication strategies aimed at increasing vaccine acceptance. Reinforcing and expanding routine immunizations amid the lingering challenges of the COVID-19 pandemic is critical to protecting the most vulnerable populations and restoring the United States’ hard-won gains against vaccine-preventable diseases.

Subject of Research: Decline in county-level MMR vaccination rates in the United States post-COVID-19 pandemic.

Article Title: Not specified in the content.

News Publication Date: Not specified beyond "published today" relative to dataset release.

Web References: None provided.

References: Data published in JAMA.

Image Credits: Johns Hopkins University.

Keywords: Viral infections, Preventive medicine

The dramatic increase in measles cases—nearly tenfold in 2024 compared to previous years—reflects deeply entrenched immunity gaps resulting from declining vaccination uptake. Despite global recognition of vaccines as one of the most powerful public health tools, preventing illnesses like measles, polio, diphtheria, and pertussis, Europe is confronting the consequences of uneven vaccine acceptance. In 2024, more than 35,000 measles cases were reported in the EU/EEA, with 23 fatalities, including 14 children under five years old, underscoring the lethal potential of the disease in vulnerable populations.

Measles virus, a highly contagious paramyxovirus, requires sustained high coverage of the measles-mumps-rubella (MMR) vaccine to interrupt transmission. The threshold to maintain herd immunity is estimated at 95% coverage with two doses. However, current vaccination rates across most EU/EEA nations fall below this critical level. Only Hungary, Malta, Portugal, and Slovakia have reported meeting or exceeding this benchmark recently. This deficit fosters ongoing pockets of susceptibility that allow outbreaks to ignite and proliferate, endangering unvaccinated individuals and those who cannot be vaccinated due to medical contraindications.

ECDC’s epidemiological analysis further highlights that the demographic impact of measles extends beyond children. Approximately 26% of cases in 2024 were individuals aged 15 and older, illustrating that immunity gaps persist into adolescence and adulthood. This shift in age distribution may reflect a cohort effect with waning immunity in older age groups or missed vaccinations during earlier life stages, emphasizing the importance of catch-up immunization campaigns targeting these populations.

Equally concerning is the detection of circulating vaccine-derived poliovirus type 2 (cVDPV2) in sewage samples from Finland, Germany, Poland, Spain, and the United Kingdom between September and December 2024. While no paralytic poliomyelitis cases have emerged in humans, the presence of cVDPV2 signals that vaccine-derived polioviruses can spread in under-immunized populations. The attenuated oral polio vaccine, widely used in global eradication efforts, can rarely revert to neurovirulent forms in settings with insufficient vaccination coverage, necessitating vigilant surveillance and robust immunization programs to preclude resurgence.

The risk posed by both measles and poliovirus elucidates the broader public health imperative: comprehensive immunization must be safeguarded to preserve the collective protection conferred by high vaccine uptake. The fragility of herd immunity means that even small declines in vaccination rates can precipitate outbreaks, burden health systems, and cause preventable morbidity and mortality.

ECDC underscores that maintaining and improving immunization coverage requires multifaceted approaches rooted in social and behavioral sciences. Understanding vaccine hesitancy—an intricate phenomenon shaped by individual beliefs, societal norms, misinformation, and trust in health authorities—is critical to crafting interventions that resonate with diverse communities. Tailoring strategies to address specific barriers and facilitators within populations forms the cornerstone of enhancing acceptance and uptake.

In support of national immunization efforts, ECDC has published a comprehensive report detailing operational tools and methodologies drawn from social and behavioral science frameworks. These resources equip public health practitioners with adaptable interventions designed to overcome vaccine hesitancy, counteract misinformation, and engage vulnerable or hard-to-reach groups effectively. The report emphasizes real-world applicability, enabling tailored approaches that reflect local contexts and cultural nuances.

In parallel with behavioral interventions, the role of digital immunization information systems is paramount. Modernized, interoperable digital registries enable health authorities to identify unvaccinated individuals, monitor coverage in real-time, and coordinate targeted outreach and catch-up campaigns. Such technological infrastructure is essential for optimizing immunization program performance and rapidly responding to emerging immunity gaps.

Sustained investment at both EU and national levels remains crucial for high-quality disease surveillance and prompt outbreak investigation capacities. Continuous data collection on vaccine-preventable diseases allows epidemiologists to detect transmission patterns, evaluate vaccination program effectiveness, and guide strategic decisions. Surveillance data drive risk assessment, inform public messaging, and support timely public health responses that mitigate the impact of outbreaks.

The resurgence of measles and detection of vaccine-derived poliovirus signify clear and urgent signals to policy makers and health authorities: the immunization gains of previous decades can be eroded swiftly without persistent vigilance. Countries must deploy a coordinated effort combining scientific insight, health communication, technological innovation, and community engagement to close vaccination gaps.

As Director of ECDC Pamela Rendi-Wagner articulates, “Thanks to vaccination we have eradicated smallpox and controlled serious diseases, such as polio, diphtheria and tetanus. The challenge for immunisation today is how to safeguard these gains. Accelerated efforts are needed to sustain high vaccination coverage. Every vaccine dose counts, and timing matters for optimal protection.” Her statement encapsulates the critical juncture at which Europe stands—a moment demanding renewed commitment to immunization as a foundation of public health security.

The EIW 2025 digital event organized by ECDC further aims to unify epidemiology and social sciences, fostering dialogue and shared solutions to address vaccination barriers and immunity gaps. By bridging disciplines and harnessing collective expertise, this initiative seeks to enhance the resilience of immunization systems in the EU/EEA and ultimately protect every community from preventable infectious diseases.

In conclusion, the data and developments spotlighted by the ECDC serve as a compelling call to action: safeguarding public health in Europe hinges on closing immunization gaps through evidence-based, community-tailored interventions, fortified surveillance, and unwavering support for vaccination programs. Only through such concerted efforts can Europe avert the threat of vaccine-preventable disease resurgence and uphold the health of its populations for generations to come.

Subject of Research: Vaccine-preventable disease resurgence and immunization coverage in Europe

Article Title: Europe Faces Critical Immunization Challenges Amid Measles Surge and Poliovirus Detections, ECDC Warns

News Publication Date: April 27, 2025

Web References:

• European Immunization Week 2025: https://www.who.int/europe/news-room/events/item/2025/04/27/default-calendar/european-immunization-week-2025
• EIW 2025 Digital Event Registration: https://bit.ly/EIW2025Event

References:

• ECDC Annual Epidemiological Report for 2024 (Available from 28 April 2025)
• Tools and methods for promoting vaccination acceptance and uptake: a social and behavioural science approach (ECDC, 2025)

Image Credits: European Centre for Disease Prevention and Control (ECDC)

Keywords: Measles, Polio, Vaccination, Immunization coverage, Vaccine-derived poliovirus, Vaccine hesitancy, Public health, EU/EEA, Infectious diseases, Immunization gaps, Disease surveillance, Herd immunity